Therapeutic Approaches Targeting Proteins in Tumor-Associated Macrophages and Their Applications in Cancers

被引:16
作者
Wu, Deyang [1 ]
Liu, Xiaowei [2 ]
Mu, Jingtian [1 ]
Yang, Jin [1 ]
Wu, Fanglong [1 ]
Zhou, Hongmei [1 ]
机构
[1] Sichuan Univ, West China Hosp Stomatol, Dept Oral Med,Frontier Innovat Ctr Dent Med Plus, State Key Lab Oral Dis,Natl Ctr Stomatol,Natl Cli, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Coll Stomatol, State Key Lab Oral Dis, Chengdu 610041, Peoples R China
基金
中国国家自然科学基金;
关键词
tumor-associated macrophages; tumor microenvironment; targeted therapy; protein; EPITHELIAL-MESENCHYMAL TRANSITION; CARCINOMA-CELL-PROLIFERATION; CHEMOKINE LIGAND 2; BREAST-CANCER; M2; MACROPHAGES; UP-REGULATION; SOLID TUMORS; PROMOTES; POLARIZATION; INHIBITION;
D O I
10.3390/biom12030392
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor-associated macrophages (TAMs) promote tumor proliferation, invasion, angiogenesis, stemness, therapeutic resistance, and immune tolerance in a protein-dependent manner. Therefore, the traditional target paradigms are often insufficient to exterminate tumor cells. These pro-tumoral functions are mediated by the subsets of macrophages that exhibit canonical protein markers, while simultaneously having unique transcriptional features, which makes the proteins expressed on TAMs promising targets during anti-tumor therapy. Herein, TAM-associated protein-dependent target strategies were developed with the aim of either reducing the numbers of TAMs or inhibiting the pro-tumoral functions of TAMs. Furthermore, the recent advances in TAMs associated with tumor metabolism and immunity were extensively exploited to repolarize these TAMs to become anti-tumor elements and reverse the immunosuppressive tumor microenvironment. In this review, we systematically summarize these current studies to fully illustrate the TAM-associated protein targets and their inhibitors, and we highlight the potential clinical applications of targeting the crosstalk among TAMs, tumor cells, and immune cells in anti-tumor therapy.
引用
收藏
页数:25
相关论文
共 180 条
[1]   CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma [J].
Advani, Ranjana ;
Flinn, Ian ;
Popplewell, Leslie ;
Forero, Andres ;
Bartlett, Nancy L. ;
Ghosh, Nilanjan ;
Kline, Justin ;
Roschewski, Mark ;
LaCasce, Ann ;
Collins, Graham P. ;
Thu Tran ;
Lynn, Judith ;
Chen, James Y. ;
Volkmer, Jens-Peter ;
Agoram, Balaji ;
Huang, Jie ;
Majeti, Ravindra ;
Weissman, Irving L. ;
Takimoto, Chris H. ;
Chao, Mark P. ;
Smith, Sonali M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (18) :1711-1721
[2]   Therapeutic Manipulation of Tumor-associated Macrophages: Facts and Hopes from a Clinical and Translational Perspective [J].
Allavena, Paola ;
Anfray, Clement ;
Ummarino, Aldo ;
Andon, Fernando Torres .
CLINICAL CANCER RESEARCH, 2021, 27 (12) :3291-3297
[3]   CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy [J].
Barkal, Amira A. ;
Brewer, Rachel E. ;
Markovic, Maxim ;
Kowarsky, Mark ;
Barkal, Sammy A. ;
Zaro, Balyn W. ;
Krishnan, Venkatesh ;
Hatakeyama, Jason ;
Dorigo, Oliver ;
Barkal, Layla J. ;
Weissman, Irving L. .
NATURE, 2019, 572 (7769) :392-+
[4]   Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy [J].
Barkal, Amira A. ;
Weiskopf, Kipp ;
Kao, Kevin S. ;
Gordon, Sydney R. ;
Rosental, Benyamin ;
Yiu, Ying Y. ;
George, Benson M. ;
Markovic, Maxim ;
Ring, Nan G. ;
Tsai, Jonathan M. ;
McKenna, Kelly M. ;
Ho, Po Yi ;
Cheng, Robin Z. ;
Chen, James Y. ;
Barkal, Layla J. ;
Ring, Aaron M. ;
Weissman, Irving L. ;
Maute, Roy L. .
NATURE IMMUNOLOGY, 2018, 19 (01) :76-+
[5]   p38 MAPK signaling in M1 macrophages results in selective elimination of M2 macrophages by MEK inhibition [J].
Baumann, Daniel ;
Drebant, Jennifer ;
Haegele, Tanja ;
Burger, Luisa ;
Serger, Clara ;
Lauenstein, Claudia ;
Dudys, Przemyslaw ;
Erdmann, Gerrit ;
Offringa, Rienk .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (07)
[6]   Kaposi's sarcoma-associated herpesvirus infection promotes differentiation and polarization of monocytes into tumor-associated macrophages [J].
Bhaskaran, Natarajan ;
Ghosh, Santosh K. ;
Yu, Xiaolan ;
Qin, Sanhai ;
Weinberg, Aaron ;
Pandiyan, Pushpa ;
Ye, Fengchun .
CELL CYCLE, 2017, 16 (17) :1611-1621
[7]   Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm [J].
Biswas, Subhra K. ;
Mantovani, Alberto .
NATURE IMMUNOLOGY, 2010, 11 (10) :889-896
[8]   The RNA-binding protein HuR inhibits expression of CCL5 and limits recruitment of macrophages into tumors [J].
Brauss, Thilo F. ;
Winslow, Sofia ;
Lampe, Sebastian ;
Scholz, Anica ;
Weigert, Andreas ;
Dehne, Nathalie ;
von Stedingk, Kristoffer ;
Schmid, Tobias ;
Bruene, Bernhard .
MOLECULAR CARCINOGENESIS, 2017, 56 (12) :2620-2629
[9]   Targeting macrophages: therapeutic approaches in cancer [J].
Cassetta, Luca ;
Pollard, Jeffrey W. .
NATURE REVIEWS DRUG DISCOVERY, 2018, 17 (12) :887-904
[10]   Symbiotic Macrophage-Glioma Cell Interactions Reveal Synthetic Lethality in PTEN-Null Glioma [J].
Chen, Peiwen ;
Zhao, Di ;
Li, Jun ;
Liang, Xin ;
Li, Jiexi ;
Chang, Andrew ;
Henry, Verlene K. ;
Lan, Zhengdao ;
Spring, Denise J. ;
Rao, Ganesh ;
Wang, Y. Alan ;
DePinho, Ronald A. .
CANCER CELL, 2019, 35 (06) :868-+